Richard Marshak

CIK: 0001982638

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (37.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)10 (62.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TLSI

TriSalus Life Sciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

TLSI
TriSalus Life Sciences, Inc.
Oct 5, 2026
Sale(S)
Direct
325 shares at avg. $4.39$1K
TLSI
TriSalus Life Sciences, Inc.
Jun 30, 2026
Award(A)
Direct
561 shares at avg. $3.87$2K
TLSI
TriSalus Life Sciences, Inc.
May 15, 2026
Sale(S)
Direct
543 shares at avg. $2.67$1K
TLSI
TriSalus Life Sciences, Inc.
Mar 16, 2026
Sale(S)
Direct
419 shares at avg. $4.12$2K
TLSI
TriSalus Life Sciences, Inc.
Mar 12, 2026
Sale(S)
Direct
1.6K shares at avg. $4.09$6K
TLSI
TriSalus Life Sciences, Inc.
Mar 11, 2026
Sale(S)
Direct
1.4K shares at avg. $4.13$6K
TLSI
TriSalus Life Sciences, Inc.
Dec 31, 2025
Award(A)
Direct
449 shares at avg. $4.38$2K
TLSI
TriSalus Life Sciences, Inc.
Nov 24, 2025
Award(A)
Direct
60K shares-
TLSI
TriSalus Life Sciences, Inc.
Jun 30, 2025
Award(A)
Direct
930 shares at avg. $4.23$4K
TLSI
TriSalus Life Sciences, Inc.
May 19, 2025
Award(A)
Direct
21.4K shares at avg. $5.18$111K
TLSI
TriSalus Life Sciences, Inc.
May 19, 2025
Sale(S)
Direct
6.6K shares at avg. $5.18$34K
TLSI
TriSalus Life Sciences, Inc.
Feb 18, 2025
Award(A)
Direct
7.6K shares-
TLSI
TriSalus Life Sciences, Inc.
Jan 27, 2025
Award(A)
Direct
12.5K shares-
TLSI
TriSalus Life Sciences, Inc.
Dec 31, 2024
Award(A)
Direct
999 shares at avg. $4.26$4K
TLSI
TriSalus Life Sciences, Inc.
Nov 14, 2024
Award(A)
Direct
6.9K shares-
TLSI
TriSalus Life Sciences, Inc.
Jun 30, 2024
Award(A)
Direct
279 shares at avg. $4.69$1K

		Type	Shares	Price		Ownership
Oct 5, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	325	$4.39	$1,427	Direct
Jun 30, 2026	TLSI TriSalus Life Sciences, Inc.	Award(A)	561	$3.87	$2,171	Direct
May 15, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	543	$2.67	$1,450	Direct
Mar 16, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	419	$4.12	$1,726	Direct
Mar 12, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	1,589	$4.09	$6,499	Direct
Mar 11, 2026	TLSI TriSalus Life Sciences, Inc.	Sale(S)	1,449	$4.13	$5,984	Direct
Dec 31, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	449	$4.38	$1,967	Direct
Nov 24, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	60,000	-	-	Direct
Jun 30, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	930	$4.23	$3,934	Direct
May 19, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	21,428	$5.18	$110,997	Direct
May 19, 2025	TLSI TriSalus Life Sciences, Inc.	Sale(S)	6,597	$5.18	$34,172	Direct
Feb 18, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	7,644	-	-	Direct
Jan 27, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	12,500	-	$0	Direct
Dec 31, 2024	TLSI TriSalus Life Sciences, Inc.	Award(A)	999	$4.26	$4,256	Direct
Nov 14, 2024	TLSI TriSalus Life Sciences, Inc.	Award(A)	6,875	-	$0	Direct
Jun 30, 2024	TLSI TriSalus Life Sciences, Inc.	Award(A)	279	$4.69	$1,309	Direct

1-16 of 16 transactions

About Marshak Richard

Marshak Richard (SEC CIK 0001982638) files insider reports with the SEC as Chief Commercial Officer of TriSalus Life Sciences, Inc. (TLSI).

Signal8 holds 10 ownership filings by Marshak Richard (9 Form 4, 1 Form 5), filed between Nov 15, 2024 and Oct 7, 2026. Those filings report 16 transactions, from Jun 30, 2024 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Marshak Richard's filings is in WESTMINSTER, CO.

Recent filings by Marshak Richard

Oct 5, 2026: Open-market sale of TLSI shares (Form 4, code S).
Jun 30, 2026: Grant or award of TLSI shares (Form 4, code A).
May 15, 2026: Open-market sale of TLSI shares (Form 4, code S).
Mar 16, 2026: Open-market sale of TLSI shares (Form 4, code S).
Mar 12, 2026: Open-market sale of TLSI shares (Form 4, code S).

Other insiders filing for TriSalus Life Sciences, Inc. (TLSI)

Cox Bryan F., Chief of Research
Stevens Jennifer, Chief Regulatory Officer
Szela Mary T, CEO and President
Patience David, Chief Financial Officer
Marshall Richard Henry, Chief Medical Officer
Wahlstrom Mats, Director

How to read Form 4 transaction codes